The observation that human AVPR1A rescued sensorimotor gating deficits in Avpr1a knockout animals provides the first evidence that our humanized mice might be useful for screening drugs targeting AVPR1A for psychiatric disorders and potential therapies for depression and violence. This evidence concerns the gene AVPR1A and depressive symptom measurement.